Financial reports
10-K
2023 FY
Annual report
13 Mar 24
10-Q
2023 Q3
Quarterly report
6 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
10-K
2022 FY
Annual report
17 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
21 Mar 22
10-Q
2021 Q3
Quarterly report
15 Nov 21
Current reports
8-K
Other Events
25 Mar 24
8-K
Indaptus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
13 Mar 24
8-K
Other Events
4 Mar 24
8-K
Amendments to Articles of Incorporation or Bylaws
23 Jan 24
8-K
Indaptus Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
6 Nov 23
8-K
Other Events
6 Nov 23
8-K
Other Events
31 Oct 23
8-K
Indaptus Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
14 Aug 23
8-K
Other Events
10 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
25 May 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
13 Mar 24
424B5
Prospectus supplement for primary offering
27 Mar 23
S-8
Registration of securities for employees
24 Mar 23
424B3
Prospectus supplement
30 Dec 22
S-1
IPO registration
23 Dec 22
RW
Registration withdrawal request
9 Sep 22
S-3
Shelf registration
1 Sep 22
S-3
Shelf registration
1 Jun 22
AW
Withdrawal of amendment
27 May 22
AW
Withdrawal of amendment
25 Mar 22
Other
EFFECT
Notice of effectiveness
3 Jan 23
CORRESP
Correspondence with SEC
30 Dec 22
UPLOAD
Letter from SEC
29 Dec 22
EFFECT
Notice of effectiveness
12 Sep 22
CORRESP
Correspondence with SEC
7 Sep 22
UPLOAD
Letter from SEC
7 Sep 22
EFFECT
Notice of effectiveness
24 Mar 22
EFFECT
Notice of effectiveness
2 Dec 21
EFFECT
Notice of effectiveness
30 Sep 21
CORRESP
Correspondence with SEC
28 Sep 21
Ownership